Millennium Management’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
Other funds holding CRVS
O
ASP
VC
PA
DTC
Millennium Management's CRVS Position: Q2 2026 in Review
Millennium Management increased its Corvus Pharmaceuticals (CRVS) stake by 21% in Q2 2026, buying an estimated $2.52M and bringing the position to 1,047,985 shares worth $15.7M. The position accounts for 0.01% of the portfolio, ranked #1856.
Millennium Management first reported a position in CRVS in Q1 2016 and has held it in 37 quarters since. 174 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.
- Millennium Management held 1,047,985 shares of Corvus Pharmaceuticals worth $15.7M as of Q2 2026.
- Millennium Management bought 181,623 Corvus Pharmaceuticals shares in Q2 2026, an estimated $2.52M.
- Corvus Pharmaceuticals made up 0.01% of Millennium Management's portfolio in Q2 2026, its #1856 holding.
- Millennium Management first reported a position in Corvus Pharmaceuticals in Q1 2016 and has held it in 37 quarters since.
- 174 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.